Generation Veeva’s Post

Discover the growing significance of #InfluencerMarketing and how it’s reshaping the pharmaceutical industry. Learn about the power of digital opinion leaders and their impact on healthcare trends: bit.ly/3xj5QWp.

We’re proud to announce that Veeva Crossix Prime Segments has been selected as one of PM360 Magazine’s most innovative products of the year. Read more below to see why nine of the top 20 biopharma companies trust Prime Segments to effectively reach precise patient audiences. https://lnkd.in/eApTVGC6 #PM360InnovationsIssue #pharma #pharmamarketing #digitalmarketing #digitaltargeting #DTCtargeting

As pharma brands become household names, what can #pharmamarketing leaders learn from their cousins in FMCG? My colleagues Erik Moen and Jenna Phillips explore in their latest article in Pharmaceutical Executive

🚀 Excited to share insights on the latest trends shaping the healthcare and pharma industry! 🏥 Check out this insightful article by Meltwater, shedding light on the dynamic landscape of healthcare and pharmaceuticals. From groundbreaking innovations to evolving consumer behaviors, this piece offers a comprehensive overview of what's driving change in the sector. Whether you're in research and development, marketing, or patient care, the insights provided in this article can help inform your strategies and decision-making processes. Let's continue to collaborate, innovate, and drive positive change in healthcare and pharma! 💡 #Healthcare #Pharmaceuticals #Innovation #IndustryInsights #Meltwater #HealthTech #LinkedInArticle #StayInformed

Presenting Company: Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing a new class of antibiotics for difficult to treat infections. The Company’s approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes late and early-stage* antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus pneumoniae (DRSP). Acurx’s lead antibiotic product candidate, oral ibezapolstat, is first in class of an entirely new class of antibiotics, DNA pol IIIC inhibitors1 recently completed a Phase 2 clinical trial in the U.S. in patients with C. difficile Infection (CDI) and is preparing to advance to Phase 3 which will include international clinical trial sites. Ibezapolstat is FDA QIDP-Fast Track Designated. 75+ Companies: https://lnkd.in/ezXG5tsx #TheMicrocapConference

Artificial intelligence holds great potential in the pharma space, but there are still some concerns to consider. 🤔 Here’s how marketers can embrace AI in their digital pharma strategies to drive engagement and conversions without compromising privacy: https://bit.ly/3S2Fq3o #AI #DigitalHealthcare #Healthgrades #Pharmaceuticals #LifeSciences

Our experts Jenna Phillips and Erik Moen share tips pharma and life sciences companies can implement as they establish effective operating models for digital opinion leaders. Read their article in Pharmaceutical Executive ⬇️

The Power of Videos in Pharmaceutical Marketing Strategies Video is a powerful tool that is often overlooked in pharmaceutical marketing. This article delves into the areas where video can drive impactful results in your campaign including: 🔷 Educational content 🔷 Demonstrating efficacy and safety 🔷 Brand awareness and trust-building 🔷 Product launches and updates 🔷 Engaging digital and social media content 🔷 Enhancing SEO and online presence 🔷 Event and conference highlights 🔷 Patient and healthcare professional testimonials Learn how video can boost your pharmaceutical marketing. https://lnkd.in/eFXTPCcX #Pharma #Marketing #PharmaMarketing #Video #VideoMarketing #Science #PharmaMarketing #VideoProduction #DigitalMarketing #MarketingAgency #CreativeServices

Are your 2024 campaigns performing at their full potential? A lot can be learned from a collaborative test and learn strategy. Check out our best practices checklist for more tips to set your campaign up for success. https://lnkd.in/eXSvsmvW #pharma #pharmamarketing #digitalmarketing #digitaltargeting #HCPtargeting #DTCtargeting #healthcare

🔊A must watch If you are a digital marketer especially in programmatic advertising for pharma industry. The Trade Desk The Trade Desk had this amazing session. ⏰ https://lnkd.in/gpMt2EsR What's happening in 2024? In January 2024, Google started rolling out a "privacy sandbox" feature in Chrome that limits the functionality of third-party cookies. This is currently affecting a small percentage of users. By the second half of 2024, Google aims to phase out third-party cookies completely in Chrome for all users. What does this mean for advertising? This presents a major challenge for advertisers who rely on third-party cookies for ad targeting and measurement. However, it also opens up opportunities for new, privacy-centric solutions to emerge. Some of the alternatives being explored include: Contextual targeting: 1.Targeting ads based on the content of the webpage or app, rather than user data. 2. First-party data: Leveraging data collected with user consent directly from their own websites or apps. 3. Cohort-based targeting: Grouping users with similar characteristics for ad targeting, without identifying individuals. #programmaticadvertising #googleads #google #ads #digitalamarketing